The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

9 Months Results

19 Nov 2008 07:12

RNS Number : 4524I
JSC Acron
19 November 2008
 

November 192008

Acron Announces IFRS Consolidated Results for 9 months of 2008

JSC Acron (LSE, RTS and MICEX: AKRN) today announces its unaudited results for the Company and its consolidated subsidiaries (the "Group") for the 9 months ended September 30, 2008.

9 Months Highlights:

Financials:

The Group's revenue reached RUB 36,295 million, up 67 per cent year-on year (nine months 2007: RUB 21,674 million);

EBITDA* rallied 221 per cent to reach RUB 16,369 million, against RUB 5,100  million in nine months of 2007;

EBITDA margin totaled 45 per cent, against 24 per cent in the same period last year;

The Group's net profit reached RUB 10,549 million - up 228 per cent year-on-year from RUB 3,212  million;

Earnings per ordinary share surged 233 per cent to reach RUB 222.58 against RUB 66.88 in nine months 2007.

*EBITDA is calculated as operating profit plus depreciation and amortization.

Note: Average exchange rate was USD 1 to RUB 24.2279 in nine months 2008 and USD 1 to RUB 25.5033 in nine months 2008

Sales:

Product

months 2008  '000 tonnes

months 2007  '000 tonnes

YOY (%)

Straight nitrogen fertilisers, incl.

1,275

1,399

-9%

Ammonia

165

235

-30%

Urea

167

255

-35%

Ammonium nitrate

731

909

-20%

Urea-ammonium nitrate

213

-

Multi-nutrient fertilisers, incl.

1,589

1,967

-19%

NPK

1,407

1,687

-17%

NP

8

42

-80%

Dry blends

174

238

-27%

Organic synthesis products, incl.

264

265

0%

Methanol

81

101

-20%

Formalin

16

22

-28%

Urea-formaldehyde resins

167

142

18%

Inorganic synthesis products, incl.

687

695

-1%

Industrial grade ammonium nitrate

207

158

31%

Liquid carbon dioxide

36

44

-18%

Calcium carbonate

354

369

-4%

Argon

5

5

0%

Hydrochloric acid

85

119

-29%

Key Developments of Q3

Acron's ordinary shares were admitted to London Stock Exchange Official List (AKRN).

Alexander Popov, chairman of Acron's Board of Directors, commenting on the Group's performance

"The results turned out to be somewhat below market expectations, as late in the third quarter Acron's performance was affected by seasonal drop in demand, which sank even deeper due to global financial crisis. 

"Amid consumers' liquidity crunch fertiliser sales have not reached their expected level. Starting from November we had to cut our fertiliser production. However, today our cash flow from operations and accumulated cash are sufficient to service our debt, pay salaries and settle trade payables. Still, all companies of the Group are cutting their costs and managing expenses.

"In Q3 Dorogobuzh decreased its fertiliser sales due to overhauls of its production facilities in September through October. Hongri Acron experienced certain difficulties selling its output in the domestic Chinese market.

"In late September, demand for mineral fertilisers plummeted in certain markets, which affected the Group's sales. However, Acron's companies have diversified product mix and, therefore, are able to switch to industrial products, which are still in stable demand. While mineral fertiliser sales are falling, industrial segment is on the rise. Thus, industrial grade ammonium nitrate sales were up 31%, sales of urea-formaldehyde resins grew 18%.

"Despite global economy turmoil, we hope to see more stable sales of mineral fertilizers. Q1 is traditionally a good one for the Group, as Russian, CIS and European companies start buying fertilisers to apply them later in the spring. Therefore, we do expect our sales to increase."

For Further Information:

Acron

Elena Kochubey -  Tel: +7 (495) 777 08 65

Corporate Communications

Ilya Popov - Tel: + 7 (495) 411 55 94 

Chief Expert 

Information and Research Department

Notes to editors

Acron is a leading Russian and global mineral fertiliser producer with a diversified product portfolio consisting of multi-nutrient fertilisers such as NPK and bulk blends, and straight nitrogen-based products such as urea, ammonium nitrate and UAN. In 2007, the Acron group's total fertiliser sales volume was 4.4 million tonnes. The Company's key markets are RussiaChina and other fast growing developing markets of South Asia, Latin America and former Soviet Union

Acron employs over 12,000 people in Russia and ChinaIn 2007 the Acron group's consolidated revenues under IFRS were RUB 31,105 million (US$ 1,267 million), and net income was RUB 5,668 million (US$ 231 million), and for the three months ended 31 March 2008 consolidated revenues under IFRS were RUB 11,661 million (US$ 496 million) and net income was RUB 3,963 million (US$ 169 million). Acron's ordinary shares are listed and traded on the MICEX, RTS and LSE stock exchanges under the symbol "AKRN". 

Acron has three production facilities - Acron (Veliky NovgorodRussia), Dorogobuzh (Smolensk Region, Russia) and Hongri Acron (Shandong ProvinceChina). Acron's logistics and transportation capabilities include its own fleet of railway cars and three sea port trans-shipment facilities on the Baltic Sea - at the Kaliningrad port of Russiaat the Estonian Sillamäe port and at the Estonian Tallinn port. The Company operates distribution networks in Russia and China.

Acron plans to enhance its vertical integration and secure supplies of phosphate and potash inputs through the development of its own mineral resource base. The Company owns licences to develop two apatite-nepheline ore deposits in the Murmansk region and a potassium-magnesium salts deposit in the Perm region (both located in Russia). 

Complete IFRS  financial statement for 9 months of 2008 is available at www.acron.ru/investor_annual.html

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTDKLBFVFBBFBK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.